The aim of this study is to compare double-balloon and spiral enteroscopy in patients with suspected small bowel lesions. Methods: Patients with suspected small bowel lesion diagnosed by capsule ...

SUMMERS ALLEGEDLY MADE THESE PILLS IN AN OFFICE SPACE HE RENTED UNDER THE NAME OF A DRYWALL COMPANY. WHEN THE OFFICE WAS RAIDED, POLICE SAID THEY FOUND A PILL PRESS, POWDERY SUBSTANCE AND LARGE ...

When taken for 40 weeks for type 2 diabetes, orforglipron resulted in an average loss of 16 pounds, or about 7.9% of the patient's body weight, at the highest dose. HealthDay News — A new pill ...

A daily pill appears to lower blood sugar in people with type 2 diabetes as effectively as injectable drugs like Ozempic and Mounjaro. The medication, called orforglipron, also led to substantial ...

Forget injections. A new drug promises to be just as effective as Ozempic — but is taken as a daily pill. Called orforglipron, the results of a new clinical trial announced Thursday by ...

The usual caveats apply to the Capsule Air, in that it's not very bright and its image isn't very accurate. But perhaps that's a high bar for something the size of a Coke can. With Google TV built ...

Novo Nordisk NOVO.B-0.10%decrease; red down pointing triangle shares fell Tuesday after Eli Lilly LLY 1.39%increase; green up pointing triangle announced results of a new pill that could rival the ...

As with the advent of new technologies, new problems arise and virtual “pill mills” stand to be one of the greatest complications as they abuse the loopholes created from telehealth platforms ...

Investing.com -- Novo Nordisk (NYSE:NVO) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE:LLY) released promising trial results for its experimental obesity pill, orforglipron ...

TSMC reported net sales up 35.3% Y/Y to $25.53B (NT$839.25B), missing estimates and declining 5.1% sequentially from $26.88B last quarter. For Q2, management is guiding for sales between $28.4B to ...

Ahmedabad: Over the past 15 years, hundreds of patients, ranging from tiny infants just six months old to senior citizens nearing 80, have been part of clinical trials conducted at VS Hospital.